Interleukin -7 mediated signalling events in early human t cell development.

Informazioni relative al progetto

ID dell’accordo di sovvenzione: HPMF-CT-1999-00057

Progetto chiuso

Data di avvio 3 Luglio 2000

Data di completamento 2 Luglio 2002

Finanziato da

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Costo totale € 140 550,00

Contributo UE € 140 550,00

Coordinato da

THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL
Netherlands

Programma(i)

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Argomento(i)

Data not available

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL

• Contributo UE: Nessun dato
• Indirizzo: 121,Plesmanlaan 121, Antoni van Leeuwenhoek Huis ; 1066 CX AMSTERDAM ; Paesi Bassi
• Costo totale: Nessun dato